Plexus (NASDAQ:PLXS) Reaches New 12-Month High - Here's What Happened

Key Points

• Shares of Plexus hit a new 52-week high of $231.25 (last $230.45) on heavy volume (~315,346 shares), supported by recent analyst price-target increases and a consensus rating of "Moderate Buy" with an average target of $194.20.
• Plexus slightly beat quarterly expectations with $1.78 EPS vs. $1.77 and $1.07B revenue (up 9.6% YoY), and issued Q2 2026 guidance of $1.80–$1.95 EPS while sell-side forecasts about 5.9 EPS for the year.
• Insiders have been net sellers recently—about 49,495 shares (~$10.0M) sold last quarter, including COO Oliver Mihm's sale of 9,541 shares (a 42.7% cut in his holdings)—even as institutional ownership remains high at 94.45%.

Shares of Plexus Corp. (NASDAQ:PLXS - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $231.25 and last traded at $230.45, with a volume of 315346 shares changing hands. The stock had previously closed at $227.58.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on PLXS. Stifel Nicolaus lifted their price target on Plexus from $150.00 to $200.00 and gave the company a "hold" rating in a research report on Friday, January 30th. Zacks Research upgraded Plexus from a "hold" rating to a "strong-buy" rating in a research report on Friday, February 6th. Needham & Company LLC lifted their price target on Plexus from $165.00 to $206.00 and gave the company a "buy" rating in a research report on Friday, January 30th. Williams Trading set a $195.00 target price on Plexus in a report on Wednesday, January 28th. Finally, Wall Street Zen cut Plexus from a "buy" rating to a "hold" rating in a report on Sunday, March 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Plexus has an average rating of "Moderate Buy" and a consensus target price of $194.20.

Plexus Stock Up 1.3%

The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $6.17 billion, a price-to-earnings ratio of 35.84 and a beta of 0.75. The stock has a fifty day moving average of $201.73 and a 200-day moving average of $170.23.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.77 by $0.01. The business had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The company's quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, sell-side analysts expect that Plexus Corp. will post 5.9 EPS for the current year.

Insiders Place Their Bets

In other news, COO Oliver K. Mihm sold 9,541 shares of the firm's stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $201.40, for a total value of $1,921,557.40. Following the completion of the sale, the chief operating officer owned 12,809 shares of the company's stock, valued at $2,579,732.60. This trade represents a 42.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Frank Zycinski sold 1,399 shares of the firm's stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $205.99, for a total value of $288,180.01. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 49,495 shares of company stock valued at $10,009,836 over the last quarter. 1.78% of the stock is owned by insiders.

Institutional Trading of Plexus

Hedge funds and other institutional investors have recently modified their holdings of the business. Salomon & Ludwin LLC acquired a new stake in shares of Plexus in the third quarter worth $30,000. Covestor Ltd boosted its position in shares of Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company's stock worth $35,000 after buying an additional 162 shares during the period. Allworth Financial LP boosted its position in shares of Plexus by 70.1% in the third quarter. Allworth Financial LP now owns 250 shares of the technology company's stock worth $36,000 after buying an additional 103 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Plexus in the third quarter worth $72,000. Finally, Farther Finance Advisors LLC boosted its position in shares of Plexus by 114.7% in the fourth quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company's stock worth $75,000 after buying an additional 273 shares during the period. Institutional investors and hedge funds own 94.45% of the company's stock.

Plexus Company Profile

Plexus Corp. NASDAQ: PLXS is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.